Intellia Therapeutics, Inc. (NTLA) Social Stream
INTELLIA THERAPEUTICS INC (NTLA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering INTELLIA THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-07 | 15 | $193 | $85 | $157.133 | $28.15 | 458.2% |
| 2022-01-28 | 16 | $193 | $85 | $156.5 | $28.15 | 455.95% |
| 2022-02-03 | 17 | $193 | $85 | $156.5 | $28.15 | 455.95% |
| 2022-02-04 | 17 | $193 | $85 | $151.437 | $28.15 | 437.96% |
| 2022-02-07 | 18 | $193 | $85 | $151.75 | $28.15 | 439.08% |
| 2022-02-25 | 19 | $193 | $85 | $151.75 | $28.15 | 439.08% |
| 2022-02-28 | 17 | $193 | $85 | $151.75 | $28.15 | 439.08% |
| 2022-03-01 | 17 | $193 | $85 | $152.375 | $28.15 | 441.3% |
| 2022-03-03 | 17 | $193 | $85 | $152.062 | $28.15 | 440.18% |
| 2022-03-07 | 18 | $193 | $85 | $148.47 | $28.15 | 427.42% |
| 2022-04-25 | 17 | $193 | $85 | $148.8 | $28.15 | 428.6% |
| 2022-05-05 | 16 | $193 | $85 | $148.8 | $28.15 | 428.6% |
| 2022-05-06 | 16 | $193 | $55 | $140.2 | $28.15 | 398.05% |
| 2022-05-09 | 16 | $193 | $55 | $138.2 | $28.15 | 390.94% |
| 2022-05-24 | 17 | $193 | $55 | $137.375 | $28.15 | 388.01% |
| 2022-06-16 | 19 | $193 | $55 | $133.411 | $28.15 | 373.93% |
| 2022-06-17 | 19 | $193 | $54 | $129 | $28.15 | 358.26% |
| 2022-07-17 | 18 | $193 | $54 | $131.437 | $28.15 | 366.92% |
| 2022-08-03 | 18 | $193 | $54 | $132.312 | $28.15 | 370.02% |
| 2022-08-05 | 18 | $193 | $54 | $132.625 | $28.15 | 371.14% |
| 2022-08-15 | 18 | $192 | $54 | $130.125 | $28.15 | 362.26% |
| 2022-09-01 | 19 | $192 | $50 | $125.411 | $28.15 | 345.51% |
| 2022-09-16 | 19 | $192 | $50 | $124.588 | $28.15 | 342.59% |
| 2022-09-19 | 19 | $192 | $50 | $125.823 | $28.15 | 346.97% |
| 2022-09-23 | 19 | $192 | $50 | $122.47 | $28.15 | 335.06% |
| 2022-10-23 | 20 | $192 | $50 | $120.333 | $28.15 | 327.47% |
| 2022-10-24 | 20 | $192 | $50 | $116.555 | $28.15 | 314.05% |
| 2022-11-01 | 21 | $192 | $50 | $117.263 | $28.15 | 316.56% |
| 2022-11-04 | 21 | $192 | $50 | $116.789 | $28.15 | 314.88% |
| 2022-11-06 | 21 | $192 | $50 | $112.157 | $28.15 | 298.43% |
| 2022-11-14 | 21 | $180 | $50 | $110.842 | $28.15 | 293.75% |
| 2022-11-15 | 21 | $180 | $50 | $111.263 | $28.15 | 295.25% |
| 2022-12-01 | 21 | $180 | $50 | $111.105 | $28.15 | 294.69% |
| 2022-12-02 | 21 | $180 | $50 | $110.894 | $28.15 | 293.94% |
| 2023-01-02 | 21 | $180 | $50 | $110.947 | $28.15 | 294.13% |
| 2023-01-04 | 22 | $180 | $50 | $111.4 | $28.15 | 295.74% |
| 2023-01-05 | 22 | $180 | $50 | $109.3 | $28.15 | 288.28% |
| 2023-01-11 | 22 | $180 | $48 | $109.05 | $28.15 | 287.39% |
| 2023-01-23 | 21 | $180 | $48 | $108.684 | $28.15 | 286.09% |
| 2023-01-26 | 21 | $180 | $39 | $108.105 | $28.15 | 284.03% |
| 2023-02-08 | 21 | $180 | $39 | $106.05 | $28.15 | 276.73% |
| 2023-02-24 | 23 | $180 | $39 | $102.3 | $28.15 | 263.41% |
| 2023-03-02 | 23 | $180 | $39 | $96.095 | $28.15 | 241.37% |
| 2023-03-14 | 23 | $180 | $39 | $96.238 | $28.15 | 241.88% |
| 2023-03-21 | 24 | $180 | $39 | $94.318 | $28.15 | 235.06% |
| 2023-03-31 | 24 | $180 | $39 | $94.181 | $28.15 | 234.57% |
| 2023-04-13 | 25 | $180 | $39 | $92.956 | $28.15 | 230.22% |
| 2023-05-05 | 25 | $180 | $39 | $92.478 | $28.15 | 228.52% |
| 2023-05-08 | 25 | $154 | $42 | $87.909 | $28.15 | 212.29% |
| 2023-06-12 | 23 | $144 | $42 | $84.761 | $28.15 | 201.1% |
| 2023-07-17 | 23 | $144 | $42 | $84.666 | $28.15 | 200.77% |
| 2023-08-04 | 24 | $144 | $42 | $84.38 | $28.15 | 199.75% |
| 2023-08-07 | 24 | $144 | $40 | $84.409 | $28.15 | 199.85% |
| 2023-10-03 | 24 | $144 | $40 | $84.181 | $28.15 | 199.04% |
| 2023-10-18 | 24 | $144 | $40 | $84.045 | $28.15 | 198.56% |
| 2023-11-02 | 23 | $144 | $40 | $82.19 | $28.15 | 191.97% |
| 2023-11-09 | 23 | $144 | $29 | $80.714 | $28.15 | 186.73% |
| 2023-11-13 | 24 | $145 | $29 | $79.045 | $28.15 | 180.8% |
The Trend in the Analyst Price Target
NTLA's average price target has moved up $50.4 over the prior 42 months.
Over the past 42 weeks, NTLA's average upside potential has been 141.53%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-26 | 23 | 180 | 39 | 96.095 | 37.74 | 154.62% |
| 2023-08-07 | 24 | 144 | 40 | 84.409 | 39.02 | 116.32% |
| 2023-10-18 | 24 | 144 | 40 | 82.523 | 27.96 | 195.15% |
| 2023-11-09 | 23 | 144 | 29 | 80.714 | 24.96 | 223.37% |
| 2023-11-13 | 24 | 145 | 29 | 77.523 | 23.81 | 225.59% |
NTLA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.38 | 19 | 1 | 4 | 0 | 0 | 24 |
The Trend in the Broker Recommendations
NTLA's average broker recommendation rating worsened by 0.13 over the prior 17 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NTLA as an investment opportunity.
- NTLA has a greater number of analysts covering the stock than 7231.16% of all US stocks.
- In terms of how INTELLIA THERAPEUTICS INC fares relative to stocks in the large market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 7640.16% of that group.
- In the context of stocks in the large market cap category, INTELLIA THERAPEUTICS INC's variance in analysts' estimates is lower than -7080.92% of them.
- NTLA has a greater average analyst price target than 6852.58% of Pharmaceutical Products stocks.
Stocks similar to INTELLIA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IDXX, QDEL, and TAK.
View All Top Stocks by Price Target
What is the outlook for NTLA? Use POWR Ratings for clearer insight into price direction.